content_image/101213.jpg
<img src='content_image/101213.jpg'>

For 2003, non-cash activities included the allocation of $6.1 million of other assets and $12.8 million in certain intangible contract- based product marketing and other rights to the purchase price for the acquisitions of Oculex Pharmaceuticals, Inc., and Bardeen Sciences Company, LLC, respectively. Additionally, the Company recorded a dividend (dividend adjustment) in the amount of $(0.3) million and $53.2 million in 2003 and 2002, respectively, related to the distribution of Advanced Medical Optics, Inc.’s common stock to the Company’s stockholders. 

